Doxorubicin Completed Phase 2 Trials for Cancer, Bladder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002919Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
NCT00506155Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer